Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001577611 | SCV001805017 | likely pathogenic | not provided | 2024-01-24 | criteria provided, single submitter | clinical testing | Observed in the homozygous state in a fetus with features of a ciliopathy in published literature; the heterozygous parents were found to have clinical features consistent with autosomal dominant polycystic kidney disease (PMID: 32055034); In-frame deletion of 1 amino acid in a non-repeat region; Not observed in large population cohorts (gnomAD); In silico analysis supports a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 34645488, 22508176, 32055034) |
Athena Diagnostics | RCV001577611 | SCV001879431 | uncertain significance | not provided | 2020-09-22 | criteria provided, single submitter | clinical testing | |
Juno Genomics, |
RCV001175219 | SCV005416382 | uncertain significance | Polycystic kidney disease, adult type | criteria provided, single submitter | clinical testing | PM2_Supporting+PM4+PS4_Supporting+PP4 | |
Fulgent Genetics, |
RCV001175219 | SCV005643264 | likely pathogenic | Polycystic kidney disease, adult type | 2024-03-06 | criteria provided, single submitter | clinical testing | |
Center for Genomic Medicine, |
RCV001175219 | SCV001338743 | likely pathogenic | Polycystic kidney disease, adult type | no assertion criteria provided | research | ||
Department of Pathology and Laboratory Medicine, |
RCV001292333 | SCV001480637 | uncertain significance | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKD1 p.Asn1450del variant was not identified in the literature nor was it identified in the dbSNP, ClinVar, LOVD 3.0, ADPKD Mutation Database, PKD1-LOVD, the Exome Aggregation Consortium (August 8th 2016) or the Genome Aggregation Database (Feb 27, 2017). This variant is an in-frame deletion resulting in the removal of an Asparagine (Asn) residue at codon 1450; the impact of this alteration on PKD1 protein function is not known. The same amino acid change caused by a different nucleotide change (PKD1, c.4347_4349del) was identified in the ADPKD Mutation Database, classified as “highly likely pathogenic.” In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. |